What is the abbreviation for primary hyperparathyroidism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

PHPT

The standard abbreviation for primary hyperparathyroidism is PHPT. This abbreviation is consistently used throughout current medical literature and clinical guidelines 1, 2, 1, 2, 3, 4, 5.

Key Points About the Abbreviation

  • PHPT is the universally accepted medical abbreviation
  • Used in both clinical practice and research settings
  • Appears in major international guidelines and consensus statements
  • Distinguishes primary hyperparathyroidism from secondary forms

The abbreviation is particularly important when documenting:

  • Persistent PHPT: Hypercalcemia persisting or recurring within 6 months post-surgery 1
  • Recurrent PHPT: Disease recurrence more than 6 months after initially curative surgery 1
  • Normocalcemic PHPT: A phenotype with elevated PTH but normal calcium levels 2

This standardized abbreviation facilitates clear communication among healthcare providers and ensures consistency in medical documentation across endocrinology, surgery, and nuclear medicine specialties 5.

References

2
Guideline

chapter 2: primary hyperparathyroidism: diagnosis.

Annales d'endocrinologie, 2025

3
Guideline

acr appropriateness criteria® parathyroid adenoma.

Journal of the American College of Radiology, 2021

4
Guideline

chapter 6: syndromic primary hyperparathyroidism.

Annales d'endocrinologie, 2025

Related Questions

Which of the following statements about hyperparathyroidism is incorrect?
In a patient with a 7-year history of progressive lower‑leg motor weakness and neuropathy due to primary hyperparathyroidism, can normalization of parathyroid function (e.g., via parathyroidectomy) lead to functional recovery?
Which of the following statements does NOT apply to primary hyperparathyroidism? A) It is the most common cause of hypercalcemia; B) It is more common in older women; C) It is characterized by low parathyroid hormone (PTH); D) Parathyroid adenoma is the most common cause; E) In a small percentage of cases, it may be familial.
What is hyperparathyroidism, including its definition, signs and symptoms, physical examination findings, and treatment options?
I have an elevated parathyroid hormone (PTH) level; what should be the next step in evaluation and management?
Is clindamycin appropriate for treating a suprapubic surgical site infection, and what dosing and adjunctive therapy should be used?
In patients with heart failure who are allergic to angiotensin receptor blockers (ARBs), what alternative medication can be used instead of the angiotensin receptor‑neprilysin inhibitor (ARNI) Entresto (sacubitril/valsartan)?
How can I safely taper down the dose of Atarax (hydroxyzine)?
What is the recommended pharmacologic and lifestyle treatment for osteoporosis, including calcium, vitamin D, bisphosphonates, denosumab, and anabolic agents?
What is the appropriate management of a skin and soft tissue infection of a colloidal scar in the suprapubic area?
What is the recommended oral bisphosphonate dosing regimen for an adult patient without esophageal disease, severe renal impairment (eGFR < 30 mL/min), hypocalcemia, or allergy to bisphosphonates?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.